ArticleEmerging infectious diseases2022

Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies.

Michael Loesche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.